Skip to content
10-K

Annual Report

Denali Therapeutics Inc. DNLI

0001714899-26-000021

← back to feed
Filed
Feb 26, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 20, 2026 158.59M sh
Shares Diluted FY 2025 · Dec 31, 2025 172.65M sh
Shares Diluted FY 2025 · Dec 31, 2024 164.47M sh
Shares Diluted FY 2025 · Dec 31, 2023 137.37M sh
Capex FY 2025 · Dec 31, 2025 $9.5M
Capex FY 2025 · Dec 31, 2024 $15.91M
Capex FY 2025 · Dec 31, 2023 $12.94M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$412.6M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$347.69M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$357.99M
Cash And Equivalents FY 2025 · Dec 31, 2025 $205.33M
Cash And Equivalents FY 2025 · Dec 31, 2024 $174.96M
Stockholders Equity FY 2025 · Dec 31, 2025 $1.01B
Stockholders Equity FY 2025 · Dec 31, 2024 $1.23B
Stockholders Equity FY 2025 · Dec 31, 2023 $1.03B
Stockholders Equity FY 2025 · Dec 31, 2022 $1.04B
Current Liabilities FY 2025 · Dec 31, 2025 $98.35M
Current Liabilities FY 2025 · Dec 31, 2024 $102.21M
Total Liabilities FY 2025 · Dec 31, 2025 $131.09M
Total Liabilities FY 2025 · Dec 31, 2024 $144.5M
Current Assets FY 2025 · Dec 31, 2025 $900.66M
Current Assets FY 2025 · Dec 31, 2024 $864.44M
Total Assets FY 2025 · Dec 31, 2025 $1.14B
Total Assets FY 2025 · Dec 31, 2024 $1.37B
Eps Diluted FY 2025 · Dec 31, 2025 −$2.97
Eps Diluted FY 2025 · Dec 31, 2024 −$2.57
Eps Diluted FY 2025 · Dec 31, 2023 −$1.06
Eps Basic FY 2025 · Dec 31, 2025 −$2.97
Eps Basic FY 2025 · Dec 31, 2024 −$2.57
Eps Basic FY 2025 · Dec 31, 2023 −$1.06
Sga Expense FY 2025 · Dec 31, 2025 $136.56M
Sga Expense FY 2025 · Dec 31, 2024 $105.44M
Sga Expense FY 2025 · Dec 31, 2023 $103.35M
Rd Expense FY 2025 · Dec 31, 2025 $418.78M
Rd Expense FY 2025 · Dec 31, 2024 $396.44M
Rd Expense FY 2025 · Dec 31, 2023 $423.88M
Net Income FY 2025 · Dec 31, 2025 −$512.54M
Net Income FY 2025 · Dec 31, 2024 −$422.77M
Net Income FY 2025 · Dec 31, 2023 −$145.22M
Operating Income FY 2025 · Dec 31, 2025 −$555.34M
Operating Income FY 2025 · Dec 31, 2024 −$487.34M
Operating Income FY 2025 · Dec 31, 2023 −$196.7M
Revenue FY 2025 · Dec 31, 2025 $0
Revenue FY 2025 · Dec 31, 2024 $0
Revenue FY 2025 · Dec 31, 2023 $330.53M